293 related articles for article (PubMed ID: 23352194)
21. Noninvasive, High-Resolution Functional Macular Imaging in Subjects With Retinal Vein Occlusion.
Campagnoli TR; Somfai GM; Tian J; DeBuc DC; Smiddy WE
Ophthalmic Surg Lasers Imaging Retina; 2017 Oct; 48(10):799-809. PubMed ID: 29020423
[TBL] [Abstract][Full Text] [Related]
22. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.
Yeh WS; Haller JA; Lanzetta P; Kuppermann BD; Wong TY; Mitchell P; Whitcup SM; Kowalski JW
Ophthalmology; 2012 Jun; 119(6):1190-8. PubMed ID: 22361318
[TBL] [Abstract][Full Text] [Related]
23. Retinal vein occlusions and mortality: the Beijing Eye Study.
Xu L; Liu WW; Wang YX; Yang H; Jonas JB
Am J Ophthalmol; 2007 Dec; 144(6):972-3. PubMed ID: 18036874
[TBL] [Abstract][Full Text] [Related]
24. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P
Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066
[TBL] [Abstract][Full Text] [Related]
25. Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 3. Retinal vascular occlusion in patients with type 2 diabetes mellitus.
Bhattacharjee H; Barman M; Misra D; Multani PK; Dhar S; Behera UC; Das T; Gilbert C; Murthy GVS; Rajalakshmi R; Pant HB;
Indian J Ophthalmol; 2020 Feb; 68(Suppl 1):S27-S31. PubMed ID: 31937725
[TBL] [Abstract][Full Text] [Related]
26. [Risk factors and visual prognosis of 407 patients with retinal vein occlusion].
Zhang HR; Xia YJ
Zhonghua Yan Ke Za Zhi; 1991 Sep; 27(5):271-4. PubMed ID: 1815918
[TBL] [Abstract][Full Text] [Related]
27. Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age-related prospective cohort study.
Sartori MT; Barbar S; Donà A; Piermarocchi S; Pilotto E; Saggiorato G; Prandoni P
Eur J Haematol; 2013 May; 90(5):426-33. PubMed ID: 23461717
[TBL] [Abstract][Full Text] [Related]
28. Poor outcomes despite aspirin or statin use in high-risk patients with retinal vein occlusion.
Matei VM; Xia JY; Nguyen C
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):761-766. PubMed ID: 28004197
[TBL] [Abstract][Full Text] [Related]
29. Retinal vessel caliber is associated with the 10-year incidence of glaucoma: the Blue Mountains Eye Study.
Kawasaki R; Wang JJ; Rochtchina E; Lee AJ; Wong TY; Mitchell P
Ophthalmology; 2013 Jan; 120(1):84-90. PubMed ID: 23062656
[TBL] [Abstract][Full Text] [Related]
30. Prevalence, pattern and risk factors of retinal vein occlusion in an elderly population in Nepal: the Bhaktapur retina study.
Thapa R; Bajimaya S; Paudyal G; Khanal S; Tan S; Thapa SS; van Rens G
BMC Ophthalmol; 2017 Sep; 17(1):162. PubMed ID: 28865424
[TBL] [Abstract][Full Text] [Related]
31. Direct medical costs and resource use for treating central and branch retinal vein occlusion in commercially insured working-age and Medicare populations.
Suñer IJ; Margolis J; Ruiz K; Tran I; Lee P
Retina; 2014 Nov; 34(11):2250-8. PubMed ID: 25046390
[TBL] [Abstract][Full Text] [Related]
32. [Telemedical-supported screening of retinal vessels ("talking eyes")].
Michelson G; Groh M; Groh MJ; Baleanu D; Harazny J; Horstmann R; Kolominsky-Rabas P
Klin Monbl Augenheilkd; 2005 Apr; 222(4):319-25. PubMed ID: 15844042
[TBL] [Abstract][Full Text] [Related]
33. Primary angle closure and primary angle closure glaucoma in retinal vein occlusion.
Xu K; Wu L; Ma Z; Liu Y; Qian F
Acta Ophthalmol; 2019 May; 97(3):e364-e372. PubMed ID: 30239140
[TBL] [Abstract][Full Text] [Related]
34. Ten-Year Incidence of Retinal Nerve Fiber Layer Defects: The Beijing Eye Study 2001/2011.
Jie R; Xu L; Wang YX; Zhang L; You QS; Yang H; Jonas JB
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5118-24. PubMed ID: 26241399
[TBL] [Abstract][Full Text] [Related]
35. The role of a second isolated retinal artery in branch retinal vein obstruction.
Lee JJ; Wu PC; Chen CH; Chen YJ; Kuo ML; Liu CC; Kuo HK
Ophthalmologica; 2005; 219(6):386-9. PubMed ID: 16286800
[TBL] [Abstract][Full Text] [Related]
36. Role of the vitreous and macular edema in branch retinal vein occlusion.
Takahashi MK; Hikichi T; Akiba J; Yoshida A; Trempe CL
Ophthalmic Surg Lasers; 1997 Apr; 28(4):294-9. PubMed ID: 9101567
[TBL] [Abstract][Full Text] [Related]
37. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials.
Varma R; Bressler NM; Suñer I; Lee P; Dolan CM; Ward J; Colman S; Rubio RG;
Ophthalmology; 2012 Oct; 119(10):2108-18. PubMed ID: 22817833
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion.
Kim M; Yu SY; Kim ES; Bae SH; Park JH; Yu HG; Kwak HW
Ophthalmologica; 2012; 227(3):132-8. PubMed ID: 22212151
[TBL] [Abstract][Full Text] [Related]
39. Serous macular detachment in branch retinal vein occlusion.
Yamaguchi Y; Otani T; Kishi S
Retina; 2006; 26(9):1029-33. PubMed ID: 17151490
[TBL] [Abstract][Full Text] [Related]
40. The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion.
McAllister IL; Gillies ME; Smithies LA; Rochtchina E; Harper CA; Daniell MD; Constable IJ; Mitchell P
Ophthalmology; 2010 May; 117(5):954-65. PubMed ID: 20163872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
